Analysing the differences in SCORAD for this trial produced a borderline significant result (0.0557) in favour of the placebo group.
← all excerpts
How Often Do Comparative Randomised Controlled Trials in the Field of Eczema Fail to Directly Compare the Treatments Being Tested?
1
—
—